PRESS RELEASE published on 02/07/2025 at 15:37, 1 year 7 months ago Franchissement de seuil Déclaration de franchissement de seuil par BlackRock Inc. pour ARKEMA avec une détention de 4,99% du capital et 3,99% des droits de vote Capital Droits De Vote Franchissement De Seuil BlackRock Inc. ARKEMA
BRIEF published on 02/03/2025 at 14:36, 1 year 7 months ago Arkema Announces Update on Shares and Voting Rights Voting Rights French Commercial Code Shares Financial Markets Authority ARKEMA
BRIEF published on 02/03/2025 at 14:36, 1 year 7 months ago Arkema annonce une mise à jour de son actionnariat et de ses droits de vote Autorité Des Marchés Financiers Actions Droit De Vote Code De Commerce Français ARKEMA
PRESS RELEASE published on 02/03/2025 at 14:31, 1 year 7 months ago Inside Information / Other news releases Correction made to the total number of voting rights as per regulatory requirements. Details provided in compliance with L.233-8 II of the French commercial code and 223-16 of the AMF Voting Rights French Commercial Code AMF Regulatory Requirements Correction
PRESS RELEASE published on 02/03/2025 at 14:31, 1 year 7 months ago Informations privilégiées / Autres communiqués Déclaration du nombre réel de droits de vote et d'actions d'une entreprise suite à une rectification. Communication réglementée conformément au Code de commerce et à la réglementation de l'AMF Déclaration Droits De Vote Code De Commerce Actions AMF
BRIEF published on 02/03/2025 at 10:08, 1 year 7 months ago Franchissement de seuil par BlackRock dans le capital d'Arkema Capital Droits De Vote Franchissement De Seuil BlackRock ARKEMA
BRIEF published on 02/03/2025 at 10:08, 1 year 7 months ago BlackRock Crosses Threshold in Arkema Capital Voting Rights Capital BlackRock Threshold Crossing ARKEMA
PRESS RELEASE published on 02/03/2025 at 10:03, 1 year 7 months ago Franchissement de seuil Déclaration de franchissement de seuil par BlackRock Inc. pour le compte de clients et fonds de 3 588 661 actions ARKEMA, représentant 4,72% du capital et 3,77% des droits de vote Déclaration Franchissement De Seuil Bourse BlackRock Inc. ARKEMA
BRIEF published on 01/28/2025 at 14:19, 1 year 7 months ago Arkema Discloses Share Buyback Transactions Share Buyback Financial Management Stock Market EU Regulation ARKEMA
BRIEF published on 01/28/2025 at 14:19, 1 year 7 months ago Arkema dévoile des opérations de rachat d'actions Rachat D'actions Bourse Gestion Financière ARKEMA Règlement De L'UE
Published on 09/11/2026 at 04:00, 6 hours 40 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 15 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 20 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 40 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 25 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 20 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 34 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 40 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 40 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 40 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 40 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 10 minutes ago Availability of the 2026 Interim Financial Report
